Sen. Lamar Alexander, D-Tenn., said at a Sept. 20 Health, Education, Labor and Pensions Panel hearing that perhaps Congress should create “an entirely new regulatory agency” to handle regulation of laboratory-developed tests (LDTs), in part because US FDA regulation of the tests would be too slow and expensive.
“Sometimes I think starting from scratch is a good idea,” he told Medtech Insight following the hearing